Marinol and Viracept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Marinol (dronabinol) and Viracept (nelfinavir mesylate). Common drug interactions include dermatitis among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Marinol and Viracept. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Marinol?

Marinol has active ingredients of dronabinol. It is often used in pain. eHealthMe is studying from 4,963 Marinol users. Check the latest studies of Marinol.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.



On Jul, 12, 2026

33 people who take Marinol and Viracept together, and have interactions are studied.

Marinol and Viracept drug interactions.

What are the common drug interactions of Marinol and Viracept, by gender? *:

female:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  3. Depression
  4. Personality disorder

male:

  1. Emotional distress
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  4. Gait disturbance
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Pain in extremity
  7. Tinnitus (a ringing in the ears)
  8. Bradycardia (abnormally slow heart action)
  9. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  10. Compression fracture (fracture due to pressure caused by injury)

What are the common drug interactions of Marinol and Viracept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Depression
  3. Personality disorder

10-19:

n/a

20-29:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Blood pressure systolic increased
  3. Chest tightness
  4. Dyspnoea (difficult or laboured respiration)
  5. Fall
  6. Heart rate irregular
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Mitral valve incompetence (inefficient heart valve)
  9. Panic attack
  10. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)

30-39:

  1. Death

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Bone density decreased
  3. Emotional distress
  4. Osteoporosis (bones weak and more likely to break)
  5. Asthenia (weakness)
  6. Depression
  7. Back pain
  8. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  9. Compression fracture (fracture due to pressure caused by injury)
  10. Decreased activity

50-59:

  1. Arthralgia (joint pain)
  2. Drug ineffective
  3. Emotional distress
  4. Myalgia (muscle pain)
  5. Pain in extremity
  6. Abnormal dreams
  7. Bone density decreased
  8. Chest pain
  9. Constipation
  10. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Blood creatinine increased
  3. Chronic kidney disease
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Emotional distress
  7. Gait disturbance
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 2 people, 6.06%
  2. Inflammation: 2 people, 6.06%
  3. Hypersensitivity: 2 people, 6.06%
  4. High Blood Pressure: 2 people, 6.06%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.06%
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 6.06%
  7. Depression: 2 people, 6.06%
  8. Blood Testosterone Decreased: 2 people, 6.06%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Marinol and Viracept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Marinol and Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Marinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Marinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viracept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dronabinol and nelfinavir mesylate (the active ingredients of Marinol and Viracept, respectively), and Marinol and Viracept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: